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Diego Rothschild and Shu Yan Ng
Abstract
Various methods have been used to treat Bell’s palsy, ranging from physical 
therapy, medications, to decompression surgery. The standard treatment is currently 
a prescription of corticosteroids with antiviral agents. All these medical approaches 
yield mixed results, and there is a need for additional investigation on treatment 
options. Recent studies have shown that facial palsy responds positively to photo-
therapy treatment, in particular the low-energy infrared laser. In the present report, 
we attempt to review the current clinical application of phototherapy, representing 
a conservative and safe medical approach in the treatment of Bell’s palsy. A literature 
review was performed. The results of the included studies suggested that low-level 
laser therapy (LLLT) is a significant treatment modality for patients recovering from 
Bell’s palsy. However, the risk of bias of the included studies was relatively high, 
and further research could change the estimate of effect of this treatment option. 
In conclusion, there is currently a moderate evidence to support the effectiveness of 
low-level laser therapy in the treatment of Bell’s palsy. Further randomized double-
blind placebo-controlled trials and high-quality studies are needed to determine with 
certainty the benefits of this treatment option for Bell’s palsy.
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1. Introduction
Bell’s palsy is an idiopathic lesion to the facial nerve, also known as cranial nerve 
VII. It is responsible for the control of the muscles of the facial mimic. It is the most 
common unilateral facial paralysis [1] and is diagnosed by excluding the other pos-
sible etiologies including congenital, neoplastic, tumors, diabetes mellitus, polyneu-
ropathy, iatrogenic, infection, trauma, and other inflammatory causes [2, 3]. Bell’s 
palsy is characterized by a rapid onset over several hours and partial or complete 
unilateral paralysis of the facial nerve without other neurologic complaints [4, 5].
This paralysis is related to an inflammation of the facial nerve near the stylo-
mastoid foramen. The main sign for Bell’s palsy is a distorted facial expression, but 
patients can experience other symptoms (e.g., taste loss, pain around the ear, or 
hearing problems [2, 6]).
With an incidence oscillating between 11 and 40 cases per 100,000 inhabit-
ants per year [7–9], Bell’s palsy represents a relatively common disease that raises 
important psychological issues because it involves the ability to express emotions, 
and a diminished facial expression interferes with social interactions [10]. Indeed, 
the face represents psychologically the most important part of the body and an 
important component of self-concept [11].
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Concerning the prognosis, some studies show that complete recovery from Bell’s 
palsy occurs in 70–85% of affected patients, whereas the remaining 15–30% dem-
onstrate incomplete recovery with symptoms such as weakness, hyperkinesia, and 
synkinetic contracture [12–14]. As for its treatment, the standard approach is currently 
a prescription of corticosteroids with antiviral agents, but there are other treatment 
options available such as surgery and physical therapy. The use of corticosteroids has 
shown opposing results in different studies. Some clinical trials showed a significant 
benefit from treating Bell’s palsy with corticosteroids [14–17]. Devriese et al. [18], 
however, demonstrated that its use has no significant effect on the outcome of this 
condition. As reported by the most reliable studies, antivirals have not been proved to 
be superior to placebo [19], surgery is disputed [17], and there are only a few con-
trolled clinical trials for the efficacy of physical therapy, massage, and facial exercises.
In this context, there is a need for additional investigation on other treatment 
options. Recent studies have shown that facial palsy responds positively to photo-
therapy treatment, in particular the low-energy infrared laser. In the present report, 
we attempt to review the current clinical application of phototherapy, representing 
a conservative and safe medical approach in the treatment of Bell’s palsy (Figure 1).
2. Low-level laser therapy and its biological effects
Lasers (light amplification by stimulated emission of radiation) were originally 
described in the 1960s by Theodore Maiman [20]. Seven years later Mester et al. 
started to investigate on low-level laser [21] and its therapeutic effects.
Figure 1. 
Patient receiving low-level laser therapy treatment for Bell’s palsy.
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Low-level laser therapy involves exposing cells or tissue to low levels of red and 
near-infrared light, to promote tissue regeneration, reduce inflammation, and relieve 
pain. It is referred to as “low level” because the energy densities are low when com-
pared to other forms of laser therapy that are used for ablation, cutting, and thermally 
coagulating tissue [22]. LLLT is also known as “cold laser” therapy as the power densi-
ties used are lower than those needed to produce heating of tissue.
LLLT has a photochemical effect which means the light is absorbed and causes a bio-
chemical change [23], but the precise mechanism is not well established. From observa-
tion, it appears that LLLT has several effects at the tissue, cellular, and even molecular 
levels. Furthermore, different applications may change its specific modes of action. At 
the cellular level, existing evidence suggests that LLLT acts on the mitochondria [24], 
stimulates the production of adenosine triphosphate (ATP) [25], modulates the reactive 
oxygen species (ROS), and which then activates the transcription factors [26].
These transcription factors, in turn, induce protein synthesis that generates 
further effects subsequently. These effects include increase of cell propagation and 
migration, modulation in cytokines levels, inflammatory mediators and growth 
factors, and augmented tissue oxygenation [27].
The mechanisms described above only partly explain the overall effects of 
LLLT. This therapy has also shown to cause vasodilation, probably related to photo-
dissociation of nitric oxide (NO) [28], which is a powerful vasodilator. This leads to 
better oxygenation of the targeted cells and also allows increased traffic of immune 
cells into tissues. Both mechanisms are linked to a faster healing.
3. Anatomy, mechanism, and etiology of Bell’s palsy
In order to understand the pathophysiology of Bell’s palsy and deduce the 
hypothetical benefits of LLLT on this condition, it is essential to know the course 
and function of the facial nerve (CN VII).
3.1 Anatomy
CN VII is responsible for the motor innervation of the facial muscles, stape-
dius, and posterior belly of the digastric muscles [29]. The facial nerve enters 
the temporal bone at the internal acoustic meatus and then continues along the 
fallopian canal before exiting through the stylomastoid foramen. It is to note that 
the thinnest portion of the fallopian canal is located in the internal auditory canal, 
at its lateral end [29].
3.2 Mechanism
The mechanism of Bell’s palsy is thought to be an inflammation of CN VII with 
a related compression in the narrow portion of the fallopian canal [30, 31]. This 
inflammation causes temporary loss of motor and sensory function and potentially 
also leads to nerve degeneration in the longer term [30].
3.3 Etiology
The cause of this neuropathy has not been firmly established, and several 
theories have been proposed. One describes Bell’s palsy as a mononeuritic 
variant of Guillain-Barre syndrome [32–34], both pathologies representing an 
inflammatory demyelinating neuritis.
Recent studies have linked Bell’s palsy to the reactivation of latent herpes virus 
in the geniculate ganglia, with migration to CN VII [35, 36]. Herpes zoster virus 
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(HZV) and herpes simplex virus 1 (HSV-1) could be related agents, with HZV 
thought to be more harmful as it disseminates over the nerve via satellite cells 
[35]. Concerning HSV-1, its DNA has even been extracted from the endoneural 
fluid of CN VII during a study from a patient suffering from acute Bell’s palsy 
[37]. Other recent studies have also shown evidence for the theory of inflamma-
tion caused by herpes simplex virus, related to nerve compression and paralysis of 
the face [14, 36, 38].
A correlation was also found between Bell’s palsy and the inactivated intra-
nasal influenza vaccine, with a risk multiplied by 19 for patients having received 
the flu vaccine as compared to that of control groups without vaccination [39]. It 
is of note that the peak incidence of the condition was at 31–60 days after vac-
cination, suggesting that an autoimmune disorder or reactivation of HSV rather 
than a direct toxic effect from the vaccine is operative [40]. This vaccine is no 
longer in use.
Other infectious etiologies that have been documented include Epstein-Barr 
virus, rubella, mumps, influenza, Coxsackievirus, adenovirus, cytomegalovirus, 
and rickettsia, with the latter being a rare cause [41, 42].
There are also noninfectious causes that have been suggested, including 
familial origin, with some 4–8% of patients reporting to have family history of 
the pathology [43], ischemia associated to atherosclerosis causing edema of the 
facial nerve [44–46], and autoimmune processes such as Hashimoto’s encepha-
lopathy [47, 48].
4. Effectiveness of LLLT for Bell’s palsy
A literature review was performed to assess the effectiveness of LLLT for the 
treatment of Bell’s palsy.
4.1 Method
4.1.1 Search strategy
An initial electronic search was constructed to identify English language studies 
that examined LLLT for Bell’s palsy. PubMed, EMBASE, PEDro, and J-Stage data-
bases were searched from inception to July 2018. The titles and abstracts have been 
screened in order to identify the relevant studies. Full-text copies of these studies 
were retrieved and considered for inclusion in this review.
4.1.2 Selection criteria
Studies were included if they were randomized and nonrandomized controlled 
trials evaluating the effectiveness of LLLT compared to other common interven-
tions or compared to a placebo/sham control in the treatment of Bell’s palsy. Studies 
were excluded if they are published in languages other than English.
4.1.3 Assessment of risk of bias for included studies
The risk of bias was assessed using the Cochrane Bias Methods Group’s criteria 
for randomized controlled trials [49] and the Effective Practice and Organization of 
Care’s criteria for nonrandomized trials [50].
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4.1.4 Data analysis
The data was extracted and reported qualitatively only, due to the heterogeneity 
of the studies.
4.1.5 Grading the strength of evidence
Strength of evidence was assessed using the GRADE Working Group grades of 
evidence [51] as follows:
• High quality: further research is very unlikely to change our confidence in the 
estimate of effect.
• Moderate quality: further research is likely to have an important impact on our 
confidence in the estimate of effect and may change the estimate.
• Low quality: further research is very likely to have an important impact on our 
confidence in the estimate of effect and is likely to change the estimate.
4.2 Results
4.2.1 Study selection
The electronic search and screening of titles and abstracts identified nine potentially 
relevant studies; they were retrieved and considered for inclusion [52–60]. Of these 
studies, five satisfied the eligibility criteria and were included in the review [52–56].
4.2.2 Study characteristics
Table 1 displays the included studies’ characteristics. Three studies were ran-
domized controlled trials, and the other two were nonrandomized controlled trials. 
All studies compared LLLT to other common treatments (group control). Only one 
study [52] included a sham/placebo laser associated to a common treatment, and 
LLLT associated to the same treatment was compared. Two studies compared the 
effectiveness of LLLT and facial exercise [52, 54]. Two studies compared LLLT with 
corticosteroids [53, 56]. One assessed the effectiveness of LLLT in comparison to 
stellate ganglion block (local anesthetic injection in the sympathetic nerve tissue 
of the neck). Treatments varied substantially in their dosage and length, from 
30 days [55] to 8.9 weeks [56]. The study samples comprised of 51, 50, 46, 52, and 
24 subjects. Finally, the outcome measurement procedures consisted in different 
recognized scales for the assessment of facial palsy severity. One study, however 
[53] also included electroneurography as one of the outcome measures.
4.2.3 Risk of bias assessment
Table 2 displays the risk of bias assessment across the included studies. One 
randomized controlled trial (RCT) [52] was found to be overall at low risk of bias. 
With that exception, all other studies were at high risk of performance bias, as no 
sham/placebo laser procedure was established, and therefore there was no blinding 
of participants. The two nonrandomized controlled trials [55, 56] had high risk of 
selection bias as opposed to the randomized controlled trials that appeared to be 
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Study Design Study sample Intervention Outcome measures Follow-up 
period
Outcome
Alayat et al. 
[52]
Randomized 
controlled trial
51 subjects with unilateral 
Bell’s palsy mean 
age = 43 ± 9.8 years
1. HILT + facial massage 
and exercise
2. LLLT + facial massage 
and exercise
3. Facial massage and 
exercise
Facial disability scale, 
House-Brackmann scale
6 weeks HILT and LLLT + facial massage and 
exercises, respectively, more effective 
than facial massage and exercises with 
sham laser
Kudoh et al. 
[53]
Randomized 
controlled trial
50 subjects with Bell’s 
palsy age ranged from 35 to 
60 years
1. LLLT + corticosteroids
2. Corticosteroids
Yanagihara evaluation 
scale, electroneurography 
(ENoG)
3 months LLLT + corticosteroids more effective 
than corticosteroids alone
Ordahan 
et al. [54]
Randomized 
controlled trial
46 subjects with unilateral 
Bell’s palsy mean age 
41 ± 9.7 years
1. LLLT + facial exercise
2. Facial exercise
Facial disability index 6 weeks LLLT + facial exercise more effective 
than facial exercise alone
Murakami 
et al. [55]
Nonrandomized 
controlled trial
52 subjects with Bell’s palsy 
age ranged from 37.1 to 
49.4 years
1. Stellate ganglion block 
(SGB)
2. LLLT
3. LLLT + SGB
Scale for assessment of 
facial palsy
>30 days LLLT + SGB as effective as SGB or LLLT 
alone, LLLT alone shows however faster 
improvement
Yamada 
et al. [56]
Nonrandomized 
controlled trial
24 subjects with Hunt’s 
syndrome II or Bell’s palsy 
age ranged from 31.1 to 59.1
1. LLLT
2. LLLT + corticosteroids
3. Corticosteroids
Scale for assessment of 
facial palsy
5.3–
8.9 weeks
LLLT as effective as corticosteroids, 
combination most effective
Table 1. 
Characteristics of included studies
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at low risk, with one study however [53] having unclear concealment in allocation. 
Concerning the detection bias, only two studies had a defined strategy for blinding 
of outcome assessment [52, 56], and the other ones therefore appeared to be at high 
risk of bias [53–55]. Finally, all studies were found to be at low risk of attrition bias. 
No other sources of bias were found, except the low number of participants in one 
of the studies [56].
4.2.4 LLLT effectiveness
Two studies [52, 54] showed that LLLT combined with facial exercise is more 
effective than facial exercise alone or in combination with a placebo laser. One study 
[53] found that LLLT combined with corticosteroids was more effective than cor-
ticosteroids alone, and another one [56] found that they are equally effective when 
prescribed separately but better when combined. Finally, the last study’s [55] results 
support that LLLT is as effective as stellate ganglion block or the combination, but 
LLLT alone shows faster effects.
4.2.5 Adverse events
Three of the included studies [53, 55, 56] specify that no side effects were noted 
following the LLLT.
4.2.6 Overall strength of the evidence
The overall strength of the evidence was moderate. Most studies did not include 
patient blinding [53–56]. Moreover, three of the five studies [53–55] did not proceed 
to a blinding of outcome assessment which substantially increases the risk of bias. 
Overall, only one study [52] showed low risk of bias and high-quality evidence. In 
other words, further research is likely to have an important impact and may change 
our confidence in the estimate of effect of LLLT for the treatment of Bell’s palsy.
4.3 Discussion
This literature review was conducted to investigate the effectiveness of LLLT for 
the treatment of Bell’s palsy. In the included studies, usual treatments such as facial 
Study Random 
sequence 
generation 
(selection 
bias)
Allocation 
concealment 
(selection 
bias)
Blinding of 
participants 
(performance 
bias)
Blinding 
of outcome 
assessment 
(detection 
bias)
Incomplete 
outcome 
data 
(attrition 
bias)
Other 
sources of 
bias
Alayat 
et al. [52]
− − − − − −
Kudoh 
et al. [53]
− ? + + − −
Ordahan 
et al. [54]
− − + + − −
Murakami 
et al. [55]
+ + + + − −
Yamada 
et al. [56]
+ + + − − +
+, high risk of bias; −, low risk of bias;?, undetermined.
Table 2. 
Risk of bias across the included studies
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exercise and corticosteroids were found to be less effective alone than when com-
bined to LLLT [52–54, 56]. Moreover, isolated LLLT and corticosteroid treatments 
were compared and found to be equally effective [56]. This suggests that LLLT is a 
significant treatment modality for patients recovering from Bell’s palsy. However, 
the lack of outcome assessment blinding [53–55] and patient blinding [53–56] in 
most studies meant that the risk of bias was relatively high and further research 
could change the estimate of effect of this treatment option. Only one study [52] 
showed low risk of bias and high-quality evidence (randomized double-blind 
placebo-controlled trial).
The understanding of the pathophysiology of Bell’s palsy helps deduce the 
related hypothetical benefits of LLLT. The physiological changes related to this 
condition have been identified during a histopathological study of the facial nerve 
over the acute pathological phase and included infiltration of inflammatory cells, 
marked edema and myelin breakdown, as well as axonal changes [61].
The photochemical and physiological changes produced by LLLT when applied 
onto the involved site in patients affected by Bell’s palsy include increase of cell 
propagation and migration, modulation in cytokines levels, inflammatory media-
tors and growth factors, and augmented tissue oxygenation [27]. They also include 
vasodilation related to photodissociation of nitric oxide (NO) [28], thus leading to 
further oxygenation of the targeted cells and allowing increased traffic of immune 
cells into tissues.
In line with these changes, we can assume that LLLT helps in controlling and 
reducing the inflammation, swelling, and edema causing compression of the facial 
nerve in its bony canal. It probably also helps improve the affected nerve’s function. 
We can also hypothesize that the augmented influx of immune cells helps fight the 
potential causative infectious agent.
Several studies support each one of these theories individually. Whether in 
fighting infectious agents such as herpes simplex virus [62], reducing inflammatory 
infiltrate [63], reducing edema [64], or helping nerve function and recovery [65], 
LLLT has shown promising results.
Furthermore, with some studies showing that complete healing occurs in 
70–85% of affected patients and the remaining 15–30% demonstrates incomplete 
recovery (weakness, hyperkinesia, and synkinetic contracture) [12–14], Bell’s palsy 
becomes an often unpredictable pathology, and spontaneous recovery cannot be 
expected. Further literature refers to a 25% of affected people with incomplete 
recovery with traditional medicines and therapies and retaining remarkable sequel 
of the pathology that may have been avertible with complementary laser treatment 
within 15 days of diagnosis [66].
In conclusion, LLLT seems to be a good complementary medium reducing the 
possibility of side effects related to facial paralysis and allowing nerve recovery. In 
addition, it is painless, has no adverse effects, and is suitable for all type of patients, 
especially those who cannot use corticosteroids, such as diabetics and hypertensive 
patients [66].
5. Conclusion
There is currently a moderate evidence to support the effectiveness of low-level 
laser therapy in the treatment of Bell’s palsy. The results of the included studies sug-
gest that LLLT may be a promising and safe treatment for this condition, but most 
of these studies were at substantial risk of bias. Further well-designed randomized 
double-blind placebo-controlled trials and high-quality studies are needed to 
determine with certainty the benefits of this treatment option for Bell’s palsy.
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ATP adenosine triphosphate
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CN VII facial nerve
HZV herpes zoster virus
HSV-1 herpes simplex virus 1
SGB stellate ganglion block
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